Comparative effectiveness board named
This article was originally published in The Gray Sheet
Executive Summary
The device sector is represented by two of the three medical product industry executives appointed to the board of governors for the new Patient-Centered Outcomes Research Institute, which was established by health care reform to direct federal comparative effectiveness research efforts. On Sept. 23, the Government Accountability Office announced its 19 selections to join two HHS officials on the board. Harlan Weisman, chief science and technology officer for Johnson & Johnson Medical Devices and Diagnostics, will serve a six-year term. Richard E. Kuntz, senior VP and chief scientific, clinical and regulatory officer for Medtronic, will sit on the board through September 2012. The drug industry is represented by a Pfizer executive. The board will be chaired by Eugene Washington, dean of the University of California, Los Angeles Medical School
You may also be interested in...
PCORI Picks Praised, But Methods Panel Will Do Most Of Work, Industry Says
Members of a federal comparative effectiveness research board appointed Sept. 23 should be effective in setting strategies and putting a public face on the board, but the real heavy lifting of the Patient-Centered Outcomes Research Institute (PCORI) will be performed by its methodology committee, industry experts are saying
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.